Inventiva S.A - Asset Resilience Ratio

Latest as of December 2025: 52.73%

Inventiva S.A (IVA) has an Asset Resilience Ratio of 52.73% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Inventiva S.A to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

€131.56 Million

≈ $153.81 Million USD Cash + Short-term Investments

Total Assets

€249.51 Million

≈ $291.70 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how Inventiva S.A's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Inventiva S.A's balance sheet.

Liquid Assets Composition Over Time

This chart breaks down Inventiva S.A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore investment intensity of Inventiva S.A to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€131.56 Million	52.73%
Total Liquid Assets	€131.56 Million	52.73%

Asset Resilience Insights

Very High Liquidity: Inventiva S.A maintains exceptional liquid asset reserves at 52.73% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Inventiva S.A Industry Peers by Asset Resilience Ratio

Compare Inventiva S.A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Aurinia Pharmaceuticals Inc NASDAQ:AUPH	Biotechnology	33.23%
Nanobiotix NASDAQ:NBTX	Biotechnology	4.71%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	65.12%

Annual Asset Resilience Ratio for Inventiva S.A (2017–2025)

The table below shows the annual Asset Resilience Ratio data for Inventiva S.A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	52.73%	€131.56 Million ≈ $153.81 Million	€249.51 Million ≈ $291.70 Million	--
2024-12-31	0.00%	€0.00 ≈ $0.00	€118.97 Million ≈ $139.08 Million	--
2023-12-31	0.10%	€70.00K ≈ $81.84K	€69.56 Million ≈ $81.32 Million	-0.80pp
2022-12-31	0.90%	€1.05 Million ≈ $1.23 Million	€116.00 Million ≈ $135.62 Million	-6.33pp
2021-12-31	7.24%	€8.83 Million ≈ $10.32 Million	€121.98 Million ≈ $142.61 Million	+1.96pp
2020-12-31	5.28%	€7.34 Million ≈ $8.58 Million	€138.92 Million ≈ $162.41 Million	+5.28pp
2017-12-31	0.00%	€-3.11K ≈ $-3.64K	€74.37 Million ≈ $86.94 Million	--

pp = percentage points

About Inventiva S.A

PA:IVA France Biotechnology

Market Cap

$833.89 Million

€713.27 Million EUR

Market Cap Rank

#9719 Global

#152 in France

Share Price

€3.44

Change (1 day)

+0.88%

52-Week Range

€2.98 - €5.98

All Time High

€15.56